[Non-motor symptoms of Parkinson's disease from pathophysiology to early diagnosis].

La Revue de médecine interne
M AubignatP Krystkowiak

Abstract

Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease. The pathophysiology of Parkinson's disease is complex and imperfectly known. Primum movens is abnormal intra-neuronal accumulation of the protein α-synuclein, leading to metabolic disturbances and neurodegeneration. This abnormal accumulation of α-synuclein is also found in dementia with Lewy bodies and multiple system atrophy, which together with Parkinson's disease form the group of α-synucleinopathies. Well known by its motor signs (bradykinesia, rest tremor, cogwheel rigidity and gait disturbance), Parkinson's disease is above all a systemic disease composed of a myriad of non-motor symptoms (constipation, sense of smell disorders, rapid eye movement sleep behaviour disorders, genitourinary disorders…). These non-motor symptoms caused by accumulation and migration of α-synuclein deposits from the gut and the olfactory bulb to the central nervous system may precede motor signs by ten years and therefore be of interest for early diagnosis. Furthermore, non-motor symptoms have a poorer impact on quality of life than motor signs themselves. Therefore, understanding, recognition and management of non-motor symptoms are crucial in m...Continue Reading

References

May 2, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·James Parkinson
Aug 15, 2002·Neurology·Tatiana WitjasA Ali Chérif
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Jun 5, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinK Ray Chaudhuri
Jul 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Kelvin L ChouKatie Kompoliti
Jun 11, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Syam KrishnanAsha Kishore
Sep 16, 2011·Parkinsonism & Related Disorders·S Rios RomenetsR B Postuma
Jan 16, 2013·Neurology·Tien K KhooDavid J Burn
Oct 15, 2013·Journal of the American Geriatrics Society·Nico J WeerkampBastiaan R Bloem
Oct 15, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Gordon W DuncanDavid J Burn
May 7, 2014·Journal of Parkinson's Disease·Wiebke SchrempfHeinz Reichmann
May 16, 2015·Journal of Neural Transmission·Kurt A Jellinger
Jul 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Fahd BaigMichele T M Hu
Sep 16, 2015·Occupational Medicine·Euan Thompson
Sep 16, 2015·Parkinsonism & Related Disorders·Ronald F Pfeiffer
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Daniela BergGünther Deuschl
Dec 15, 2015·Neuropathology and Applied Neurobiology·Kelly Del Tredici, Heiko Braak
Jan 1, 2016·Revue neurologique·A ElbazF Moisan
Mar 26, 2016·Parkinsonism & Related Disorders·Valeria D FeliceSiobhain M O'Mahony
Jul 15, 2016·Brain : a Journal of Neurology·Rimona S WeilHuw R Morris
Jul 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Raul Martínez-FernándezPaul Krack
Nov 2, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Eduardo De Pablo-FernándezThomas T Warner
Jan 21, 2017·Nature Reviews. Neurology·Dominic H FfytcheDag Aarsland
Mar 4, 2017·Nature Reviews. Neurology·Dag AarslandClive Ballard
Mar 24, 2017·Nature Reviews. Disease Primers·Werner PoeweAnthony E Lang
Apr 30, 2017·Trends in Pharmacological Sciences·Miranda E OrrBess Frost
May 17, 2017·Seminars in Neurology·Christine Y Kim, Roy N Alcalay
Sep 10, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·J A ObesoA J Stoessl
Dec 27, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Aristide MerolaAlberto J Espay
Mar 24, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Susan H FoxUNKNOWN Movement Disorder Society Evidence-Based Medicine Committee
Apr 8, 2018·Neurology·Gennaro PaganoMarios Politis
May 15, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Juliane WinkelmannCristina Sampaio
Jun 26, 2018·Parkinsonism & Related Disorders·Juliane MatlachStephan Klebe
Aug 27, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Mathilde WanneveichPierre Joly
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Klaus SeppiUNKNOWN the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders So
Feb 2, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R DurcanUNKNOWN ICICLE-PD Study Group
Mar 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B Postuma, Daniela Berg
Apr 15, 2019·Lancet Neurology·Lucilla ParnettiPaolo Calabresi
May 7, 2019·Frontiers in Neurology·Emilia M Gatto, Victoria Aldinio
May 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H EvansUNKNOWN Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee
Aug 15, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian HeinzelUNKNOWN MDS Task Force on the Definition of Parkinson's Disease
Nov 20, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Chiara BaianoGabriella Santangelo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Parkinson's Disease
Irena RektorovaAntonio P Strafella
Parkinson's Disease
Shey-Lin WuYuan-Han Yang
Expert Review of Neurotherapeutics
Anna HusslWerner Poewe
Arquivos de neuro-psiquiatria
Egberto Reis Barbosa
Expert Review of Neurotherapeutics
Kaylena A Ehgoetz Martens, James M Shine
© 2021 Meta ULC. All rights reserved